Welcome to “Fly Insider,” The Fly’s weekly recap of notable insider stock transactions.
NOTABLE INSIDER PURCHASES: Significant insider purchases reported in the prior week from June 19 through June 23 include:
- Shareholder of Zentalis Pharmaceuticals (ZNTL) Matrix Capital purchased 4,760,000 shares of company stock at $22.66 per share for a total transaction amount of $107,861,600
- Chairman of Asana (ASAN) Dustin Moskovitz purchased 240,000 shares of company stock at $23.16 per share for a total transaction amount of $5,559,168
- Director of Brown & Brown (BRO) Edmund Masojada purchased 4,000 shares of company stock at $65.78 per share for a total transaction amount of $263,120
- Chairman of Howard Hughes Corp (HHC) Ackman William purchased 62,498 shares of company stock at $74.80 per share for a total transaction amount of $4,674,894
NOTABLE INSIDER SALES: Significant insider sales in the prior week from June 19 through June 23 include:
- Director of Adobe (ADBE) John Warnock sold 3,000 shares of company stock at $481.41 per share for a total transaction amount of $1,444,228
- CFO of American Superconductor (AMSC) John Kosiba John sold 29,878 shares of company stock at $5.95 per share for a total transaction amount of $177,816
- Director of ChargePoint Holdings (CHPT) Michael Linse sold 59,465 shares of company stock at $144.26 per share for a total transaction amount of $8,578,480
- CEO of CrowdStrike Holdings (CRWD) George Kurtz sold 59,465 shares of company stock at $144.26 per share for a total transaction amount of $8,578,480
NOTABLE PRICE MOVEMENT AFTER INSIDER TRANSACTION: Shares of Howard Hughes Corp move higher by 1.5% after chairman William Ackman purchased 62,498 shares at $74.80 per share, while CrowdStrike moved lower by 2% after CEO George Kurtz sold 59,465 shares of company stock at $144.26 per share.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ZNTL:
- Zentalis management to meet with Oppenheimer
- Take a Look at Zentalis Stock’s (NASDAQ:ZNTL) Enormous Insider Trade
- Zentalis 11.033M share Secondary priced at $22.66
- Zentalis Pharmaceuticals Announces Pricing of Underwritten Offering of Common Stock
- Zentalis Announces Intermittent Azenosertib Monotherapy Dosing Nearly Doubles Efficacy Over Continuous Dosing
Questions or Comments about the article? Write to editor@tipranks.com